None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Men and women aged 40 to under 65 years 2. Individuals who have not been managing their diet within the past 3 months 3. Individuals who meet the criteria for obesity or overweight: - Body mass index (BMI) of 23 or higher - Abdominal obesity according to the WHO Asian criteria: waist circumference of 90 cm or greater for men and 80 cm or greater for women 4. Individuals with stable body weight, defined as a weight change of no more than 3 kg within the past 3 months 5. Individuals who can walk independently and perform low-intensity exercise without difficulty 6. Smartphone owners who are able to use an application and participate in monitoring 7. Individuals who already own a massage chair or plan to purchase or rent one 8. Individuals who have access to a massage chair at home, a fitness center, a welfare facility, or the workplace Participants must meet at least one of criteria 7 or 8.
Exclusion criteria
Exclusion criteria: 1. Individuals diagnosed within the past 6 months with a severe medical condition, dementia, cognitive impairment, epilepsy, or a similar condition 2. Individuals who have difficulty walking due to a musculoskeletal condition such as degenerative spinal disease or joint disease 3. Individuals with lower-limb disability due to a neurological condition such as brain disease 4. Individuals taking anticoagulants or having a condition that causes a bleeding tendency 5. Individuals with a history of a psychiatric disorder such as schizophrenia, severe depression, or anxiety disorder 6. Individuals with severe hearing or visual impairment 7. Individuals for whom use of the massage chair is inappropriate due to a skin disease, acute inflammatory disease, osteoporosis, or a similar condition 8. Individuals who have difficulty understanding the study procedures or providing consent due to cognitive impairment 9. Individuals currently participating in another clinical study within the past 3 months 10. Individuals who have used medication or injections for weight loss within the past 3 months 11. Individuals with severe obesity, defined as a body mass index (BMI) of 30 or higher 12. Women who are pregnant or may be pregnant 13. Individuals with an internal metal implant, such as an artificial joint or spinal fixation screw
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in habit formation level from baseline to week 12 (SRBAI score);Changes in body weight and obesity-related indicators from baseline to week 12 [body weight (kg), whole-body fat mass (kg) and lean mass (kg) measured by DXA, and waist circumference (cm)] | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in waist-to-hip ratio (WHR);Change in abdominal tilt angle;Change in abdominal silhouette ;Change in body fat percentage;Change in muscle mass;Change in weight-loss self-efficacy measured by the WELQ;Chatbot usage (intervention adherence [%]);Change in handgrip strength;Change in perceived body lightness score after the five-times sit-to-stand test;Change in dietary habits;Change in sleep quality;Change in step count (measured using the default health application and other step-tracking applications);Change in low-back and knee pain intensity measured by the VAS;Change in blood pressure | — |
Countries
Korea, Republic of
Contacts
Yonsei University